azilect rasagiline mesylate 0.5 mg

1 INDICATIONS AND USAGE AZILECT (rasagiline tablets) is indicated for the treatment of Parkinson’s disease (PD). AZILECT, a monoamine oxidase (MAO)-B inhibitor (MAOI), is indicated for the treatment of Parkinson’s disease ( 1 )

teva neuroscience, inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] off label use` `[4] nausea` `[5] pain` `[6] diarrhoea` `[7] headache` `[8] dizziness` `[9] dyspnoea` `[10] fall`

1 month ago

ROUND WHITE GIL 0 5

16 HOW SUPPLIED/STORAGE AND HANDLING AZILECT 0.5 mg Tablets: white to off-white, round, flat, beveled tablets, debossed with “GIL 0.5” on one side and plain on the other side. Supplied as bottles of 30 tablets (NDC 68546-142-56). AZILECT 1 mg Tablets: white to off-white, round, flat, beveled tablets, debossed with “GIL 1” on one side and plain on the other side. Supplied as bottles of 30 tablets (NDC 68546-229-56). Storage: Store at 25°C (77°F) with excursions permitted to 15°-30°C (59°-86°F).

More pills like ROUND GIL 0 5

Related Pills

rasagiline 1 MG Oral Tablet Azilect

Teva Neuroscience, Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site